Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways.
about
Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Mycophenolate mofetil and curc ...... 1 and renal dopamine pathways.
@en
Mycophenolate mofetil and curc ...... 1 and renal dopamine pathways.
@nl
type
label
Mycophenolate mofetil and curc ...... 1 and renal dopamine pathways.
@en
Mycophenolate mofetil and curc ...... 1 and renal dopamine pathways.
@nl
prefLabel
Mycophenolate mofetil and curc ...... 1 and renal dopamine pathways.
@en
Mycophenolate mofetil and curc ...... 1 and renal dopamine pathways.
@nl
P2093
P2860
P1476
Mycophenolate mofetil and curc ...... p1 and renal dopamine pathways
@en
P2093
Abraham S Arellano
Ana B Jiménez-Flores
Edilia Tapia
Eduardo Molina-Jijón
Fernando García-Arroyo
Horacio Osorio-Alonso
José Pedraza-Chaverri
Magdalena Cristobal
Octaviano Silverio
Virgilia Soto
P2860
P304
P356
10.1080/10715762.2016.1174776
P577
2016-05-04T00:00:00Z